The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Zika Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
The global Zika Vaccines market size is expected to reach US$ 18530 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Zika Vaccines in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgery Centers and Others, are propelling Zika Vaccines market. Therapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Preventive Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zika Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zika Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zika Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zika Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zika Vaccines covered in this report include Bharat Biotech, Inovio Pharmaceuticals, Cerus Corporation, Sanofi, NewLink Genetics, Immunovaccine and GlaxoSmithKline, etc.
The global Zika Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Inovio Pharmaceuticals
Cerus Corporation
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Global Zika Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zika Vaccines market, Segment by Type:
Therapeutic Vaccines
Preventive Vaccines
Global Zika Vaccines market, by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Zika Vaccines market size is expected to reach US$ 18530 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Zika Vaccines in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgery Centers and Others, are propelling Zika Vaccines market. Therapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Preventive Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zika Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zika Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zika Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zika Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zika Vaccines covered in this report include Bharat Biotech, Inovio Pharmaceuticals, Cerus Corporation, Sanofi, NewLink Genetics, Immunovaccine and GlaxoSmithKline, etc.
The global Zika Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Inovio Pharmaceuticals
Cerus Corporation
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Global Zika Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zika Vaccines market, Segment by Type:
Therapeutic Vaccines
Preventive Vaccines
Global Zika Vaccines market, by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Zika Vaccines Market Overview
1.1 Zika Vaccines Product Overview
1.2 Zika Vaccines Market Segment by Type
1.2.1 Therapeutic Vaccines
1.2.2 Preventive Vaccines
1.3 Global Zika Vaccines Market Size by Type
1.3.1 Global Zika Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Zika Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Zika Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Zika Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Zika Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Zika Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Zika Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Zika Vaccines Sales Breakdown by Type (2018-2023)
2 Global Zika Vaccines Market Competition by Company
2.1 Global Top Players by Zika Vaccines Sales (2018-2023)
2.2 Global Top Players by Zika Vaccines Revenue (2018-2023)
2.3 Global Top Players by Zika Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Zika Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Zika Vaccines Market Competitive Situation and Trends
2.5.1 Zika Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Zika Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zika Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Zika Vaccines Market
2.8 Key Manufacturers Zika Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Zika Vaccines Status and Outlook by Region
3.1 Global Zika Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Zika Vaccines Historic Market Size by Region
3.2.1 Global Zika Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Zika Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Zika Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Zika Vaccines Forecasted Market Size by Region
3.3.1 Global Zika Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Zika Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Zika Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Zika Vaccines by Application
4.1 Zika Vaccines Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgery Centers
4.1.4 Others
4.2 Global Zika Vaccines Market Size by Application
4.2.1 Global Zika Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Zika Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Zika Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Zika Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Zika Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Zika Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Zika Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Zika Vaccines Sales Breakdown by Application (2018-2023)
5 North America Zika Vaccines by Country
5.1 North America Zika Vaccines Historic Market Size by Country
5.1.1 North America Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Zika Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Zika Vaccines Sales in Value by Country (2018-2023)
5.2 North America Zika Vaccines Forecasted Market Size by Country
5.2.1 North America Zika Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Zika Vaccines Sales in Value by Country (2024-2029)
6 Europe Zika Vaccines by Country
6.1 Europe Zika Vaccines Historic Market Size by Country
6.1.1 Europe Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Zika Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Zika Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Zika Vaccines Forecasted Market Size by Country
6.2.1 Europe Zika Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Zika Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Zika Vaccines by Region
7.1 Asia-Pacific Zika Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Zika Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Zika Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Zika Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Zika Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Zika Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Zika Vaccines Sales in Value by Region (2024-2029)
8 Latin America Zika Vaccines by Country
8.1 Latin America Zika Vaccines Historic Market Size by Country
8.1.1 Latin America Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Zika Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Zika Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Zika Vaccines Forecasted Market Size by Country
8.2.1 Latin America Zika Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Zika Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Zika Vaccines by Country
9.1 Middle East and Africa Zika Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Zika Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Zika Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Zika Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Zika Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Zika Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bharat Biotech Zika Vaccines Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Inovio Pharmaceuticals
10.2.1 Inovio Pharmaceuticals Company Information
10.2.2 Inovio Pharmaceuticals Introduction and Business Overview
10.2.3 Inovio Pharmaceuticals Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Inovio Pharmaceuticals Zika Vaccines Products Offered
10.2.5 Inovio Pharmaceuticals Recent Development
10.3 Cerus Corporation
10.3.1 Cerus Corporation Company Information
10.3.2 Cerus Corporation Introduction and Business Overview
10.3.3 Cerus Corporation Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cerus Corporation Zika Vaccines Products Offered
10.3.5 Cerus Corporation Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Zika Vaccines Products Offered
10.4.5 Sanofi Recent Development
10.5 NewLink Genetics
10.5.1 NewLink Genetics Company Information
10.5.2 NewLink Genetics Introduction and Business Overview
10.5.3 NewLink Genetics Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 NewLink Genetics Zika Vaccines Products Offered
10.5.5 NewLink Genetics Recent Development
10.6 Immunovaccine
10.6.1 Immunovaccine Company Information
10.6.2 Immunovaccine Introduction and Business Overview
10.6.3 Immunovaccine Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Immunovaccine Zika Vaccines Products Offered
10.6.5 Immunovaccine Recent Development
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Information
10.7.2 GlaxoSmithKline Introduction and Business Overview
10.7.3 GlaxoSmithKline Zika Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GlaxoSmithKline Zika Vaccines Products Offered
10.7.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Zika Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Zika Vaccines Industrial Chain Analysis
11.4 Zika Vaccines Market Dynamics
11.4.1 Zika Vaccines Industry Trends
11.4.2 Zika Vaccines Market Drivers
11.4.3 Zika Vaccines Market Challenges
11.4.4 Zika Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Zika Vaccines Distributors
12.3 Zika Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
